Mediators of Inflammation

Mediators of Inflammation / 2016 / Article

Corrigendum | Open Access

Volume 2016 |Article ID 2856829 | 1 page | https://doi.org/10.1155/2016/2856829

Corrigendum to “Sphingosine-1-Phosphate Signaling in Immune Cells and Inflammation: Roles and Therapeutic Potential”

Received16 Aug 2016
Accepted04 Sep 2016
Published24 Oct 2016

In the article titled “Sphingosine-1-Phosphate Signaling in Immune Cells and Inflammation: Roles and Therapeutic Potential” [1], there was an error in the “FTY720 and Lymphopenia” section, where the sentence “p-FTY720 causes continued cAMP signaling that is not dependent on S1P1R redistribution and induces functional antagonism of Ca2+ signaling after transient stimulation” should be corrected to “p-FTY720 causes continued cAMP signaling that is not dependent on S1PR1 redistribution and induces functional antagonism of Ca2+ signaling after transient stimulation.”

References

  1. M. Aoki, H. Aoki, R. Ramanathan, N. C. Hait, and K. Takabe, “Sphingosine-1-phosphate signaling in immune cells and inflammation: roles and therapeutic potential,” Mediators of Inflammation, vol. 2016, Article ID 8606878, 11 pages, 2016. View at: Publisher Site | Google Scholar

Copyright © 2016 Masayo Aoki et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

612 Views | 214 Downloads | 4 Citations
 PDF  Download Citation  Citation
 Download other formatsMore
 Order printed copiesOrder

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19.